Dr. Reddy's Laboratories Ltd. And TRPharm Announce Strategic Collaboration In Turkey

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s and TR-Pharm announced today a strategic collaboration agreement involving 3 biosimilar products. A total of three products will be registered and subsequently commercialized as a part of this agreement by TR-Pharm in Turkey. TR-Pharm will also manufacture the drug substance and drug product upon completion of its facility investment.

Back to news